President Trump’s executive order suspending federal funding for gain-of-function research not only contains questionable assertions, but it also frames the targeted research so broadly that it is likely to affect even lower-risk infectious disease research.
Related Posts
America’s Supplement Obsession Could Go Into Overdrive
In a Massachusetts cellar in 1873, Lydia Pinkham first brewed the elixir that would make her famous. The dirt-brown liquid, made from herbs including black […]
Families of Transgender Youth No Longer View Colorado as a Haven for Gender-Affirming Care
Rae Ellen Bichell Illustration by Oona Zenda In recent years, states across the Mountain West have passed laws that limit doctors from providing transgender children […]
I’m Sensing Some Future – The Health Care Blog
By KIM BELLARD One of my frequent laments is that here we are, a quarter of the way into the 21st century, yet too much […]